Appendix 3B - Proposed issue of securities Appendix 3B - Proposed issue of securities 1 / 5 Announcement Summary Entity name BCAL DIAGNOSTICS LIMITED Announcement Type New announcement Date of this announcement 21/8/2026 The Proposed issue is: Total number of +securities proposed to be...
Proposed issue of securities - BDX
Filed with ASX · · 5 pages · English
Release
BCAL Diagnostics Limited on 6ix
Earlier from BCAL Diagnostics
- Bioshares Conference Investor Presentation
- Quarterly Activities/Appendix 4C Cash Flow Report
- BCAL to Acquire Shares in Genetic Signatures
- BCAL Secures Funding for FY2027
- BCAL Develops New Blood Test for Breast Cancer Recurrence
Later from BCAL Diagnostics
- Notification regarding unquoted securities - BDX
- BCAL Secures Funding for FY2027 Update
- Change in Substantial Shareholder Notice for GSS
- BCAL Takes Interest in Genetic Signatures to 18.46%
- Appendix 4G and Corporate Governance Statement
Follow BCAL Diagnostics into a list and get an email when it puts out news.
Follow BCAL Diagnostics